Evidence map›Paper›PMID 41933089›Full record

ArticleScientific reports2026

Sustainable synthesis of bimetallic Cu-Ag nanoparticles using waste-derived chitosan and citrus extract: a green approach to combat antimicrobial resistance.

Saburi Abimbola Atanda, Foluso Oyedotun Agunbiade, Rafiu Olarewaju Shaibu

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saburi Abimbola AtandaDepartment of Chemistry, University of Lagos, Akoka-Yaba, Lagos, Nigeria. the19icon@gmail.com.ORCID http://orcid.org/0000-0001-5509-6140
Foluso Oyedotun AgunbiadeDepartment of Chemistry, University of Lagos, Akoka-Yaba, Lagos, Nigeria.
Rafiu Olarewaju ShaibuDepartment of Chemistry, University of Lagos, Akoka-Yaba, Lagos, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing threat of antimicrobial resistance necessitates innovative strategies that combine efficacy with environmental sustainability. Current methods for synthesizing bimetallic copper-silver nanoparticles often rely on hazardous chemicals or costly reagents, limiting sustainable production. This study presents a dual waste valorization approach to synthesize bimetallic Cu-Ag nanoparticles using Citrus sinensis peel extract as a reducing agent and chitosan from Archachatina marginata shells as a stabilizer in a single-pot aqueous process. Mild conditions (60 °C, atmospheric pressure, 4 h) avoided toxic solvents while transforming two abundant regional waste streams into functional nanomaterials. Chemical characterization confirmed the extract's reducing capacity: total phenolic content (1.759 mg GAE/g), total flavonoid content (0.298 mg QE/g), and antioxidant activity (DPPH: 62.61%; FRAP: 0.965 AU; HPS: 73.50% at 100 µg/mL). Nanoparticle formation was verified by surface plasmon resonance at 405 nm (UV-Vis), chitosan-metal coordination (FTIR), face-centered cubic structure with Cu incorporation (XRD, crystallite size 28 ± 1.4 nm), and quasi-polygonal morphology (TEM, 50.3 ± 12.8 nm). Williamson-Hall analysis indicated low compressive microstrain (ε = - 0.323 × 10⁻

Indexed as

Anti-Bacterial AgentsChitosanCitrusCopperMetal NanoparticlesPlant ExtractsSilverAntioxidantsGreen Chemistry TechnologyMicrobial Sensitivity TestsAnti-Bacterial AgentsAntioxidantsChitosanCopperPlant ExtractsSilverBiopolymer stabilizerEco-friendly nanomaterialsPathogen inhibitionSurface plasmon resonanceThermal stability

Identifiers

PMID41933089
PMCPMC13195045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.